CA1214092A - Detection of rearranged dna - Google Patents
Detection of rearranged dnaInfo
- Publication number
- CA1214092A CA1214092A CA000447937A CA447937A CA1214092A CA 1214092 A CA1214092 A CA 1214092A CA 000447937 A CA000447937 A CA 000447937A CA 447937 A CA447937 A CA 447937A CA 1214092 A CA1214092 A CA 1214092A
- Authority
- CA
- Canada
- Prior art keywords
- cells
- dna
- fragment
- human
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000001514 detection method Methods 0.000 title description 4
- 239000012634 fragment Substances 0.000 claims abstract description 22
- 239000000523 sample Substances 0.000 claims abstract description 16
- 230000008707 rearrangement Effects 0.000 claims abstract description 10
- 238000009396 hybridization Methods 0.000 claims abstract description 8
- 108700020796 Oncogene Proteins 0.000 claims abstract description 6
- 102000043276 Oncogene Human genes 0.000 claims abstract description 4
- 108020004414 DNA Proteins 0.000 claims description 18
- 230000003211 malignant effect Effects 0.000 claims description 10
- 208000011691 Burkitt lymphomas Diseases 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000012472 biological sample Substances 0.000 claims description 2
- 230000008711 chromosomal rearrangement Effects 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 18
- 108700024542 myc Genes Proteins 0.000 description 5
- 230000005945 translocation Effects 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 101001070329 Geobacillus stearothermophilus 50S ribosomal protein L18 Proteins 0.000 description 3
- 101100326370 Mus musculus Bst1 gene Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- MJQHZNBUODTQTK-UHFFFAOYSA-N 2-[[3-[2-[(3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OC1C(O)C(O)C(CO)OC1OC1C2OCC1OC(OC1C(C(OC3C4OCC3OC(O)C4O)OC(CO)C1O)O)C2O MJQHZNBUODTQTK-UHFFFAOYSA-N 0.000 description 1
- 208000034951 Genetic Translocation Diseases 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 101150039798 MYC gene Proteins 0.000 description 1
- 206010064912 Malignant transformation Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 208000007452 Plasmacytoma Diseases 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 102000053563 human MYC Human genes 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000036212 malign transformation Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229940079938 nitrocellulose Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/469,797 US4542096A (en) | 1983-02-25 | 1983-02-25 | Detecting rearranged human c-myc DNA fragments associated with oncogenes |
US469,797 | 1983-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1214092A true CA1214092A (en) | 1986-11-18 |
Family
ID=23865095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000447937A Expired CA1214092A (en) | 1983-02-25 | 1984-02-21 | Detection of rearranged dna |
Country Status (6)
Country | Link |
---|---|
US (1) | US4542096A (en, 2012) |
EP (1) | EP0117727A3 (en, 2012) |
JP (1) | JPS59224566A (en, 2012) |
CA (1) | CA1214092A (en, 2012) |
DK (1) | DK98584A (en, 2012) |
GR (1) | GR81659B (en, 2012) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4681840A (en) * | 1984-01-18 | 1987-07-21 | The United States Of America As Represented By The Secretary Of Commerce | Deoxyribonucleic acid molecules useful as probes for detecting oncogenes incorporated into chromosomal DNA |
US4857466A (en) * | 1984-09-28 | 1989-08-15 | The Board Of Regents Of The University Of Texas System | Probe for detection of specific human leukemias |
IL76997A0 (en) * | 1984-11-14 | 1986-04-29 | Oncogene Science Inc | Probes and methods useful for detecting chromosomal translocation |
JPS61162752A (ja) * | 1985-01-11 | 1986-07-23 | Sekisui Chem Co Ltd | Dnaおよび/またはrnaの検出法 |
US4892829A (en) * | 1986-04-22 | 1990-01-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Human plasma cell line having rearranged c-myc proto-oncogene |
US5320941A (en) * | 1986-06-06 | 1994-06-14 | Dallan Young | DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom |
JPH02500323A (ja) * | 1986-08-13 | 1990-02-08 | ザ、ゼネラル、ホスピタル、コーポレーション | 結腸病変用検出マーカー |
IL84007A0 (en) * | 1986-10-08 | 1988-02-29 | Gen Hospital Corp | Recombinant dna molecules which contain a plant-derived genetic sequence for glyceraldehyde phosphate dehydrogenase and a method of producing plant glyceraldehyde phosphate dehydrogenase |
DE3721400A1 (de) * | 1987-06-29 | 1989-01-12 | Viktor Dr Dr Med Balazs | Verfahren zur untersuchung einer azellularen biologischen fluessigkeit auf zellulare onkogen-dna bzw. deren fragmente |
US5066792A (en) * | 1987-09-04 | 1991-11-19 | Board Of Regents University Of Texas | Gene probe for detection of specific human leukemias |
WO1992006220A1 (en) * | 1990-10-05 | 1992-04-16 | President And Fellows Of Harvard College | Detection and isolation of ligands |
US6160106A (en) * | 1993-10-12 | 2000-12-12 | Yeda Research & Development Co., Ltd. | Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
IL107250A (en) * | 1993-10-12 | 2001-08-08 | Yeda Res & Dev | Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins |
DE19932890A1 (de) * | 1999-07-19 | 2001-02-01 | Deutsches Krebsforsch | DNA zum Nachweis von Veränderungen des Chromosoms 8 |
WO2011132078A2 (en) * | 2010-04-23 | 2011-10-27 | Genomic Vision | Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492985A1 (fr) * | 1980-10-24 | 1982-04-30 | Pasteur Institut | Procede d'etude et de detection d'un gene susceptible d'etre transcrit en un arn messager determine et de la capacite des cellules ou d'une fraction cellulaire d'en assurer la transcription et application au diagnostic in vitro de maladies dues a des anomalies genetiques ou a des adn etrangers |
US4358535A (en) * | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
-
1983
- 1983-02-25 US US06/469,797 patent/US4542096A/en not_active Expired - Fee Related
-
1984
- 1984-02-21 GR GR73861A patent/GR81659B/el unknown
- 1984-02-21 CA CA000447937A patent/CA1214092A/en not_active Expired
- 1984-02-23 EP EP84301179A patent/EP0117727A3/en not_active Withdrawn
- 1984-02-24 JP JP59032717A patent/JPS59224566A/ja active Pending
- 1984-02-24 DK DK98584A patent/DK98584A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK98584D0 (da) | 1984-02-24 |
EP0117727A2 (en) | 1984-09-05 |
US4542096A (en) | 1985-09-17 |
DK98584A (da) | 1984-08-26 |
EP0117727A3 (en) | 1988-01-20 |
GR81659B (en, 2012) | 1984-12-12 |
JPS59224566A (ja) | 1984-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1214092A (en) | Detection of rearranged dna | |
US4681840A (en) | Deoxyribonucleic acid molecules useful as probes for detecting oncogenes incorporated into chromosomal DNA | |
US5272057A (en) | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase | |
Rovigatti et al. | Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia | |
De Martinville et al. | Localization of DNA sequences in region Xp21 of the human X chromosome: search for molecular markers close to the Duchenne muscular dystrophy locus | |
Hagemeijer et al. | Translocation of c-abl to “masked” Ph in chronic myeloid leukemia | |
Kelsey et al. | A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans | |
Schleiermacher et al. | Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain | |
Schleiermacher et al. | Variety and complexity of chromosome 17 translocations in neuroblastoma | |
DE69704031T2 (de) | Test zur diagnose eines erhöhten brustkrebs-risikos | |
Feldenzer et al. | Heterogeneity of DNA fragments associated with the sickle-globin gene. | |
Lidereau et al. | Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients. | |
Winqvist et al. | Human ornithine decarboxylase sequences map to chromosome regions 2pter→ p23 and 7cen→ qter but are not coamplified with the NMYC oncogene | |
Kukita et al. | Molecular gene mapping of human aldolase A (ALDOA) gene to chromosome 16 | |
Patterson et al. | Genetic and physical mapping of a novel region close to the fragile X site on the human X chromosome | |
Leibowitz et al. | Increased Expression of a Novel c-abc-Related RNA in K562 Cells | |
Daiger et al. | Multiple, independent restriction site polymorphisms in human DNA detected with a cDNA probe to argininosuccinate synthetase (AS) | |
Boomer et al. | Detection of E2A translocations in leukemias via fluorescence in situ hybridization | |
Van Ooteghem et al. | A new B-cell line showing a complex translocation (8; 14; 18) and BCL2 rearrangement | |
Patterson et al. | An intronic region within the human factor VIII gene is duplicated within Xq28 and is homologous to the polymorphic locus DXS115 (767) | |
Graham et al. | The use of restriction fragment polymorphisms to identify the cell line MCF-7 | |
Kaelbling et al. | DNA polymorphisms indicate loss of heterozygosity for chromosome 11 of D98AH2 cells | |
Den Dunnen et al. | All six rat γ-crystallin genes are located on chromosome 9 | |
Cave et al. | Deletion of chromosomal region 13q14. 3 in childhood acute lymphoblastic leukemia | |
Reid et al. | High‐resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |